ProPhase Labs, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $20.8M | $31.4M | $6.8M |
| FY2021 | $30.7M | $89.3M | $8.4M |
| FY2022 | $24.0M | $87.6M | $9.1M |
| FY2023 | $42.5M | $91.9M | $1.6M |
| FY2024 | $55.8M | $63.2M | $678.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $20.8M | $31.4M | $6.8M |
| FY2021 | $30.7M | $89.3M | $8.4M |
| FY2022 | $24.0M | $87.6M | $9.1M |
| FY2023 | $42.5M | $91.9M | $1.6M |
| FY2024 | $55.8M | $63.2M | $678.0K |